TEVA(TEVA) - 2024 Q4 - Annual Results

EXHIBIT 99.1 Teva Delivers Second Consecutive Year of Growth; Announces Strong Financial Results in Fourth Quarter and Full Year 2024, Led by Generics Performance and Innovative Portfolio Growth Q4 2024 and FY 2024 highlights: | | Q4 2024 | FY 2024 | | --- | --- | --- | | Revenues | $4.2 billion | $16.5 billion | | GAAP loss per share | $0.19 | $1.45 | | Non-GAAP diluted EPS | $0.71 | $2.49 | | | | $1,247 | | Cash flow generated from operating activities | $575 million | million | | | | $2,068 | | Free cash ...